Cargando…
T1D progression is associated with loss of CD3(+)CD56(+) regulatory T cells that control CD8(+) T cell effector functions
An unresolved issue in autoimmunity is the lack of surrogate biomarkers of immunological self-tolerance for disease monitoring. Here, we show that peripheral frequency of a regulatory T cell population, characterized by the co-expression of CD3 and CD56 molecules (T(R3-56)), is reduced in subjects w...
Autores principales: | Terrazzano, Giuseppe, Bruzzaniti, Sara, Rubino, Valentina, Santopaolo, Marianna, Palatucci, Anna Teresa, Giovazzino, Angela, La Rocca, Claudia, de Candia, Paola, Puca, Annibale, Perna, Francesco, Procaccini, Claudio, De Rosa, Veronica, Porcellini, Chiara, De Simone, Salvatore, Fattorusso, Valentina, Porcellini, Antonio, Mozzillo, Enza, Troncone, Riccardo, Franzese, Adriana, Ludvigsson, Johnny, Matarese, Giuseppe, Ruggiero, Giuseppina, Galgani, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272221/ https://www.ncbi.nlm.nih.gov/pubmed/32500117 http://dx.doi.org/10.1038/s42255-020-0173-1 |
Ejemplares similares
-
CD4(+) T Cell Defects in a Mulibrey Patient With Specific TRIM37 Mutations
por: Bruzzaniti, Sara, et al.
Publicado: (2020) -
Blood Co-Circulating Extracellular microRNAs and Immune Cell Subsets Associate with Type 1 Diabetes Severity
por: Garavelli, Silvia, et al.
Publicado: (2020) -
Bone marrow CD3
(+)
CD56
(+) regulatory T lymphocytes (T(R3)
(−56) cells) are inversely associated with activation and expansion of bone marrow cytotoxic T cells in IPSS‐R very‐low/low risk MDS patients
por: Leone, Stefania, et al.
Publicado: (2022) -
An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
por: Terrazzano, Giuseppe, et al.
Publicado: (2020) -
Leptin modulates autophagy in human CD4(+)CD25(−) conventional T cells
por: Cassano, Silvana, et al.
Publicado: (2014)